123 related articles for article (PubMed ID: 33785718)
1. Changes in expression of TLR-4, TGF-β, INF-γ, TNF-α in cultured T24/83 cells of invasive bladder cancer treated with cisplatin and/or polyphenolic adjuvant melanin.
Yakovlev PG; Gorbach OI; Khranovska NM; Beliayeva AV; Skachkova OV; Skaterna TD; Kalachniuk LG; Ostapchenko LI; Garmanchuk LV
Exp Oncol; 2021 Mar; 43(1):7-14. PubMed ID: 33785718
[TBL] [Abstract][Full Text] [Related]
2. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin.
Mizutani Y; Nakao M; Ogawa O; Yoshida O; Bonavida B; Miki T
J Urol; 2001 Jan; 165(1):263-70. PubMed ID: 11125422
[TBL] [Abstract][Full Text] [Related]
3. Expression of TLR4 and major inflammatory cytokines in patients with bladder cancer of different grade and stage.
Yakovlev PG; Gorbach OI; Ostapchenko LI; Garmanchuk LV; Skachkova OV; Khranovska NM; Senchylo NV
Exp Oncol; 2021 Jun; 43(2):142-148. PubMed ID: 34190522
[TBL] [Abstract][Full Text] [Related]
4. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
5. Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer.
Lin W; Sun J; Sadahira T; Xu N; Wada K; Liu C; Araki M; Xu A; Watanabe M; Nasu Y; Huang P
Int J Biol Sci; 2021; 17(12):3255-3267. PubMed ID: 34421363
[TBL] [Abstract][Full Text] [Related]
6. Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma through apoptosis pathway.
Ping SY; Wu CL; Yu DS
Urol Oncol; 2012 Sep; 30(5):652-9. PubMed ID: 20884251
[TBL] [Abstract][Full Text] [Related]
7. Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
Naito S; Hasegawa S; Yokomizo A; Koga H; Kotoh S; Kuwano M; Kumazawa J
Jpn J Cancer Res; 1995 Nov; 86(11):1112-8. PubMed ID: 8567404
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of c-myc expression by tumor necrosis factor-alpha in combination with transforming growth factor-beta or interferon-gamma with concomitant inhibition of proliferation in human cell lines.
Hori M; Kamijo R; Takeda K; Nagumo M
J Interferon Res; 1994 Apr; 14(2):49-55. PubMed ID: 8077765
[TBL] [Abstract][Full Text] [Related]
9. Loss of p73 induction in a cisplatin-resistant bladder cancer cell line.
Ono Y; Nonomura N; Harada Y; Fukui T; Tokizane T; Sato E; Nakayama M; Nishimura K; Takahara S; Okuyama A
Mol Urol; 2001; 5(1):25-30. PubMed ID: 11689148
[TBL] [Abstract][Full Text] [Related]
10. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
[TBL] [Abstract][Full Text] [Related]
11. MLN4924 Synergistically Enhances Cisplatin-induced Cytotoxicity via JNK and Bcl-xL Pathways in Human Urothelial Carcinoma.
Ho IL; Kuo KL; Liu SH; Chang HC; Hsieh JT; Wu JT; Chiang CK; Lin WC; Tsai YC; Chou CT; Hsu CH; Pu YS; Shi CS; Huang KH
Sci Rep; 2015 Nov; 5():16948. PubMed ID: 26592553
[TBL] [Abstract][Full Text] [Related]
12. Enhanced sensitivity of bladder cancer cells to cisplatin mediated cytotoxicity and apoptosis in vitro and in vivo by the selective cyclooxygenase-2 inhibitor JTE-522.
Mizutani Y; Nakanishi H; Li YN; Sato N; Kawauchi A; Miki T
J Urol; 2004 Oct; 172(4 Pt 1):1474-9. PubMed ID: 15371874
[TBL] [Abstract][Full Text] [Related]
13. Suppression of HAX-1 induced by miR-325 resensitizes bladder cancer cells to cisplatin-induced apoptosis.
Li R; Zheng JZ; Huang X
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9303-9314. PubMed ID: 33015771
[TBL] [Abstract][Full Text] [Related]
14. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine/Cisplatin Treatment Induces Concomitant SERTAD1, CDKN2B and GADD45A Modulation and Cellular Changes in Bladder Cancer Cells Regardless of the Site of TP53 Mutation.
da Silva GN; Filoni LT; Salvadori MC; Salvadori DMF
Pathol Oncol Res; 2018 Apr; 24(2):407-417. PubMed ID: 28577130
[TBL] [Abstract][Full Text] [Related]
16. Human urinary bladder cancer T24 cells are susceptible to the Antrodia camphorata extracts.
Peng CC; Chen KC; Peng RY; Su CH; Hsieh-Li HM
Cancer Lett; 2006 Nov; 243(1):109-19. PubMed ID: 16455193
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of TGF-beta receptor I by siRNA suppresses the motility and invasiveness of T24 bladder cancer cells via modulation of integrins and matrix metalloproteinase.
Li Y; Yang K; Mao Q; Zheng X; Kong D; Xie L
Int Urol Nephrol; 2010 Jun; 42(2):315-23. PubMed ID: 19669587
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of FTO promotes proliferation and migration, and protects bladder cancer cells from cisplatin-induced cytotoxicity.
Wen L; Pan X; Yu Y; Yang B
BMC Urol; 2020 Apr; 20(1):39. PubMed ID: 32299393
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition after exposure to transforming growth factor-β1 in human bladder cancer cell lines.
Lee C; Lee SH; Kim DS; Jeon YS; Lee NK; Lee SE
Korean J Urol; 2014 Jul; 55(7):487-92. PubMed ID: 25045449
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma up-regulates toll-like receptor 4 and cooperates with lipopolysaccharide to produce macrophage-derived chemokine and interferon-gamma inducible protein-10 in human bladder cancer cell line RT4.
Yamada H; Odonnell MA; Matsumoto T; Luo Y
J Urol; 2005 Sep; 174(3):1119-23. PubMed ID: 16094077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
